February 15, 2018 (Vol. 38, No. 4)


The Expedeon TruePrime™ apoptotic cell-free DNA (cfDNA) amplification kit enables accurate DNA amplification using cfDNA obtained from plasma, serum, urine, cerebrospinal fluid, or many other bodily fluids. This kit uses a novel multiple-displacement amplification method to overcome the common limitations with the analysis of bodily fluid for cfDNA analysis. By exponentially amplifying cfDNA derived from apoptosis, the cell-death mechanism, these TruePrime kits provide users with excellent sensitivity, error-free amplification in high yields, and a streamlined workflow for reduced hands-on time. 

Previous articleSmart Contacts Can Monitor the Glucose in Tears
Next articleNIH Budget Proposal